NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs051190039

Registered date:21/08/2019

HAKUOH Study

Basic Information

Recruitment status Not Recruiting
Health condition(s) or Problem(s) studiedUterine cervical cancer
Date of first enrollment21/08/2019
Target sample size2100
Countries of recruitment
Study typeInterventional
Intervention(s)arm A:vaccine group 3 times(0 month, 2 month, 6 month) arm B:non-vaccine group

Outcome(s)

Primary OutcomePersistent inflectional rate
Secondary OutcomeVaccinationrate by age group,Persistent inflectional rate by age group

Key inclusion & exclusion criteria

Age minimum>= 27age old
Age maximum<= 45age old
GenderFemale
Include criteriaInclusion criteria: >Women with normal cytology results confirmed in cervical cancer screening programs from May 2019 to March 2020 >27-45 years-old >Intact uterus >Willing to undergo the HPV-DNA test (cobas4800) within 12 months
Exclude criteriaExclusion criteria >Pregnant women >Undergo treatment or the follow-up evaluation for CIN within the previous 12 months >Previously administered HPV vaccine

Related Information

Contact

Public contact
Name Akiko Shinagawa
Address 23-3Matsuoka Shimoaiduki,Eiheiji-cho,Yoshida-gun,Fukui Fukui Japan 910-1193
Telephone +81-776-61-8392
E-mail hakuoh@ml.u-fukui.ac.jp
Affiliation University of Fukui Hospital
Scientific contact
Name Yoshio Yoshida
Address 23-3Matsuoka Shimoaiduki,Eiheiji-cho,Yoshida-gun,Fukui Fukui Japan 910-1193
Telephone +81-776-61-8392
E-mail yyoshida@u-fukui.ac.jp
Affiliation University of Fukui Hospital